Actos Cancer [ Cross-Platform ]

While the drug remains on the market in the U.S., the FDA prescribing information now includes warnings about the potential bladder cancer risk. 3. Warning Signs and Symptoms

Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months). ACTOS CANCER

Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer While the drug remains on the market in the U

Never stop taking a prescribed diabetes medication without medical advice. Discuss your concerns and potential alternatives with your healthcare provider. Actos is a brand-name prescription drug (generic name:

Because of allegations that the manufacturer failed to adequately warn patients and doctors about the cancer risks, thousands of lawsuits were filed.

In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..

In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug.